Myocardial infarction and Ischemic heart disease Flashcards

1
Q

How does ischemia occur in the heart?

A

When myocardial oxygen supply fails to meet myocardial demand myocardial, ischemia results. Myocardial ischemia is an imbalance between myocardial oxygen supply and demand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Myocardial Ischemia is the result of an imbalance between myocardial oxygen supply and myocardial oxygen demand. Explain the factors that lead to oxygen supply and demand?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blockage of coronary artery?

A

Blockage or occlusion of a coronary artery reduces coronary blood flow. A reduction in coronary blood flow reduces myocardial oxygen supply. In this case, oxygen supply may not meet oxygen demand (requirements), resulting in hypoxia. Hypoxia produces electrophysiological and mechanical changes in the heart and ultimately lead to cellular death and total loss of electrical activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypoxic conditions do what to ATP concentrations? what are the effects of this?

A

Hypoxic conditions reduce intracellular concentrations of ATP. Reduced ATP decreases the activity of ATP-dependent transport systems, including the Na+/K+-ATPase pump. This pump transports K+ into the cell and Na+ out of the cell. The Na+/K+-ATPase pump is electrogenic, meaning it normally produces hyperpolarizing currents. Decreased activity therefore, causes membrane depolarization because of the loss of hyperpolarizing currents.

Moreover, loss of the Na+/K+-ATPase pump prevents K+ from being pumped back into the cell so that its extracellular concentration increases as its intracellular concentration falls. This causes membrane depolarization.

Reduced concentrations of ATP also affect the movement of K+ through KATP channels which open when there is reduced ATP. Thus, hypoxia and reduced ATP lead to an outward movement of K+, which initially can lead to hyperpolarization; however, excessive outward movement of K+ leads to an increase in extracelluar K+ and membrane depolarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain how Reduced concentrations of ATP affect contractility and relaxation?

A

Hypoxia and reduced ATP also negatively impacts movement (“ratcheting”) between the myosin heads and the actin (see below) and calcium sequestration by the sarcoplasmic reticulum by an ATP-dependent calcium pump (SERCA, sarcoendoplasmic reticulum calcium-ATPase)

Hypoxia also results in anaerobic metabolism with the production of hydrogen ions. Intracellular H+ accumulates and activates the Na/H exchanger resulting in the exchange of Na (into the cell) for H (out of the cell). Depolarization inactivates fast Na++ channels and, as a result, decreases action potential upstroke velocity by inhibiting fast Na+ channels. Inhibiting fast sodium channels causes a decreased conduction velocity. Cellular depolarization and decreased conduction velocity contribute to arrhythmias. The reduction in ATP along with these events alter myocardial excitationcontraction coupling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain excitation contraction in the heart?

A

An action potential causes a myocyte to depolarize and calcium ions enter the cell during phase 2 of the action potential through L-type calcium channels located on the sarcolemma. This calcium triggers the release of calcium from the sarcoplasmic reticulum (SR) through calcium-release channels (“ryanodine receptors”). Calcium released by the SR increases the intracellular calcium concentration. The free calcium binds to troponin-C (TN-C) This induces a conformational change in the regulatory complex such that troponin I (TN-I) exposes a site on the actin molecule that is able to bind to the myosin ATPase located on the myosin head. This binding results in ATP hydrolysis and movement (“ratcheting”) between the myosin heads and the actin.

Ratcheting cycles occur as long as the cytosolic calcium remains elevated. At the end of phase 2, calcium entry into the cell slows and calcium is sequestered by the SR by an ATP-dependent calcium pump (SERCA, sarco-endoplasmic reticulum calciumATPase), thus lowering the cytosolic calcium concentration and removing calcium from the TN-C. Calcium is also transported out of the cell by the sodium-calcium-exchange pump and the Ca ATPase. The reduced intracellular calcium induces a conformational change in the troponin complex leading, once again, to TN-I inhibition of the actin binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain myocardial ischemia effects on the sympathetic system?

A

Myocardial Ischemia also activates the sympathetic Nervous System. The sympathetic system increases inotropy (contractility) and lusitropy (relaxation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The ischemia myocardium does what to diastolic function?

A

By inhibiting the Na+/K+-ATPase, hypoxia cause intracellular sodium concentration to increase. This then leads to an accumulation of intracellular calcium via the Na+-Ca++ exchange system. Hypoxia and reduced ATP also reduces activity of sarcoplasmic reticulum (SR) and plasma membrane (PM) calcium pumps. This also increases diastolic calcium levels making more calcium available to bind to troponin-C, which reduces relaxation.

An accumulation of intracellular sodium causes the sodium / calcium exchanger to work in the “reverse” mode bring more calcium into the cell.

High intracellular calcium prevents TN-I inhibition of the actin binding site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The ischemia myocardium effects on systolic function?

A

The reduced ATP reduces cross bridge cycling. In addition, since less calcium is sequestered by the SR, less calcium is released. Pi and hydrogen limit Calcium binding to troponin C.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ischemic myocardium effects on arrhythmia’s?

A

Decreased activity of the calcium pumps increases diastolic calcium. The increased calcium is exchanged for sodium triggering depolarization or triggered after depolarizations.

Reduced activity of the sodium potassium pump also raises membrane potential leading to conduction block and re-entry.
Norepinephrine binds to beta receptors increasing cAMP and PKA. PKA opens potassium and calcium channels leading to altered membrane excitability and arrhythmias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

explain the fick principle?

A

The Fick principle (Adolph Fick, 1870) can be written:
Myocardial oxygen consumption = Coronary Blood Flow X Coronary Arterial – Coronary Venous Oxygen Content (arterio-venous oxygen difference).

  • About 75% of the oxygen in arterial blood is extracted as blood passes through the resting myocardium
  • This means that any substantial increase in oxygen consumption must be accompanied by increased Coronary Blood Flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

increased coronary blood flow primarily results from? Caused by?

A
  • Increased coronary blood flow primarily results from dilatation of coronary arterioles.
  • Dilatation of arterioles is caused by the accumulation of metabolites including adenosine, potassium ion, CO2, and H+ as well as some paracrines including prostaglandins.
  • Large distributing arteries also dilate because the increased flow brought about by dilatation of arterioles causes the endothelium of large arteries to release nitric oxide. Nitric Oxide diffuses from endothelium to smooth muscle and causes dilatation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the paracrine and endothelial factors that lead to vasoconstriction and vasodilation?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Extravascular compression during systole does what to coronary flow? with tachycardia?

A

Extravascular compression during systole reduces coronary flow. Most of the coronary blood flow to the left ventricle occurs during diastole because during systole the contracting myocardium compresses coronary vessels.

Because of extravascular compression, the endocardium is more susceptible to ischemia.

This is of greater importance at lower perfusion pressures.

Importantly, with tachycardia there is relatively less time available for coronary flow during diastole to occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is coronary autoregulation?

A

Autoregulation is the intrinsic ability of an organ to maintain a constant blood flow despite changes in perfusion pressure. The autoregulatory range is the range of pressure over which there is little if any change in blood flow.

Vascular smooth muscle depolarizes when stretched. Depolarization increases calcium entry and promotes smooth muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Increased sympathetic nervous system activity does what?

A

Increased sympathetic nervous system activity increases afterload, preload, contractility and Heart Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the primary factor determining myocardial oxygen consumption? What are things increase MVO2?

A

Myocyte contraction is the primary factor determining myocardial oxygen consumption (MVO2). Accordingly, factors that enhance tension development by the cardiac muscle cells, the rate of tension development, or the number of tension generating cycles per unit time will increase MVO2.
For example, doubling Heart Rate approximately doubles MVO2 because ventricular myocyte generates twice the number of tension cycles per minute.
Increasing inotropy increases MVO2 because the rate of tension development is increased as well as the magnitude of tension, both of which result in increased ATP hydrolysis and oxygen consumption.
Increasing afterload (arterial pressure), because it increases tension development, also increases MVO2.

Increasing preload (e.g., ventricular end-diastolic volume) also increases MVO2; however, the increase is much less than what might be expected because of the LaPlace relationship.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain wall tension? increasing Ventricular volume increases wall tension how? Increasing intraventricular pressure by 100% does what to wall tension?

A

The LaPlace relationship says that wall tension (T) is proportional to the product of intraventricular pressure (P) and ventricular radius (r).

Wall tension is the tension generated by myocytes that results in a given intraventricular pressure at a particular ventricular radius. Therefore, when the ventricle needs to generate greater pressure, for example with increased afterload or inotropic stimulation, the wall tension is increased. In addition, a dilated ventricle (as occurs in dilated cardiomyopathy) must generate increased wall tension to produce the same intraventricular pressure.

Ventricular preload volume does not affect MVO2 to the same extent as changes in afterload. This is because preload is usually expressed as the ventricular end-diastolic volume. Because the ventricle is a sphere with many radii, the radius does not proportionally effect MVO2.

Thus a 100% increase in ventricular volume (V) increases wall tension (T) by only
26%.
In contrast, increasing intraventricular pressure (P) by 100% increases wall tension (T) by 100%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Increasing heart rate, aortic pressure, inotropy, does what to MVO2? With myocardial hypertrophy force development is? this does what?

A

In summary, increasing heart rate, aortic pressure, inotropy, increase MVO2 about 4-times more than an equivalent percent change in stroke volume.

With myocardial hypertrophy, force development is spread over more sarcomeres, reducing the load on any one sarcomere. This reduces the oxygen requirements of any one sarcomere. However: with hypertrophy, growth of blood vessels does not keep pace with growth of cardiac cells and the demand for oxygen increases out of proportion with capacity to supply oxygen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is ischemic heart disease?

A

IHD comprises a series of clinical syndromes whose evolution is due to chronic ischemia. IHD is the leading cause of death in the US, and so prevention, screening, and therapeutics are of course actively engaged across the medical system.

At its core, IHD is an imbalance between myocardial demand and actual myocardial perfusion, resulting over time in myocardial (myocyte) cell injury, potential cell death, tissue repair, and states of new cardiac functioning/homeostasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the etiologies of the perfusion imbalance in ischemic heart disease?

A

The etiologies of the perfusion imbalance:

  • Atherosclerosis: 90%+ of IHD is due to atherosclerotic narrowing of the (medium-sized) coronary arteries, so much so that another name for IHD is coronary artery disease (CAD). Atherosclerosis involves the coronary arteries most prominently at their takeoffs and extends for a certain distance. As in the schematic, when present enough to cause symptoms of IHD, often all three arteries will be affected to a reasonable degree, and quantifying their relative occlusion will help guide therapies, stratify immediate risk, etc.
  • Vasospasm: recall that vessels can undergo uncoordinated contraction sequences in response to unknown factors, resulting in generally less blood flow at somewhat unpredictable times. One of the known factors that can induce vasospasm is the presence of atherosclerosis.
  • Vasculitis: inflammation affecting the coronary arteries will impact their function.
  • Emboli: physical occlusion of coronary arteries by emboli of any type is problematic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the clinical symptoms of myocardial ischemia?

A
  • angina, which can further evolve into myocardial infarction
  • sudden cardiac death (may or may not be related to some degree of infarction)
  • chronic ischemic heart disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Stable angina happens with what?

A

This most common form occurs when over (roughly) 75% atherosclerotic occlusion is present (see image) and the patient is asymptomatic at rest, but then increased demand becomes necessary and it’s unable to be met.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Unstable or cresendo angina happens when what pathology happens?

A

Chest pain at rest can evolve when the atherosclerotic plaque becomes so severe that demand outstrips perfusion when no activity is occurring and/or plaque complexity/plaque rupture/vessel vasospasm causes severe occlusion. In the right panel below, plaque rupture has caused thrombus formation, which is causing near total occlusion (arrow). The chest pain of unstable angina may change in quality, location, or duration (vs. stable angina). These patients are at high risk for further evolution towards infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Prinzmetal angina is usually due to?

A

Prinzmetal (variant) angina – this uncommon form of chest pain is unrelated to physical activity, can even occur when sleeping, is usually due to vasospasm, and is readily relieved by vasodilator therapy.

Truism in biology… vasospasm leads to clinical symptoms in affected vessels, and named diseases, such as migraine headaches, Raynaud phenomena, variant angina, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Classic symptoms of MI?

A

These days, patients with chest pain are evaluated in a systematic manner to rule in/out an MI: history, physical exam, ECG findings, and serologic evidence of myocyte death. Classic symptomatology starts the evaluation:

  • chest pain of longer duration (often >30 minutes)
  • chest pain of a different quality (stabbing, sharp, crushing)
  • rapid and/or weak pulse
  • sweating (sometimes profuse)
  • nausea and/or vomiting
  • dyspnea as backflow congestion into pulmonary vessels occurs
  • asymptomatic (such as in diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Treatment strategy of MI?

A

Of course, prompt reperfusion is desired in order to limit damage and/or salvage as many myocytes as possible.

Truism… Injury to cells the duration or severity pushes past tipping point leads to irreversible cell injury/cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

patters of infarction begin to show as?

A

Patterns of infarction begin to show as particular coronary arteries are implicated in the ischemic process. Logically, if a patient is known to have significant disease in a particular coronary artery, it’s more likely their pattern of infarction will represent that pathology.

29
Q

Pathology of transmural infarcts defined as? common etiologies?

A

are more commonly seen, and are defined as infarction affecting the entire wall thickness (or > 50% of it). Advanced or complicated atherosclerosis, plaque rupture, and/or overlying thrombosis are typical etiologies. (Think: stable angina progressing to unstable angina progressing to fully occlusive MI symptoms). o ST elevation myocardial infarction (STEMI)

30
Q

Non-transmural infarcts defined as? what is most susceptible to ischemia? etiologies?

A

are less commonly seen, and are defined as infarction affecting less than 1/2 of the wall thickness (or very little of it). Note the subendocardium (under the endocardial surface; the endocardium proper can get oxygen from luminal diffusion) is most susceptible to ischemia because it’s at the end of the coronary artery circulation. States of systemic hypoperfusion (shock) put the subendocardium at risk, along with every other body tissue near the end of terminal circulation (watershed areas, etc). The pattern of myocyte damage is usually circumferential (middle heart ring of the right side schematic above) because all of the end-circulation capillaries are poorly perfused. o non-ST elevation myocardial infarction (NSTEMI)

31
Q

Microinfarcts etiologies?

A

are very uncommon, and may be seen in special circumstances: a showering of tiny emboli lodging in capillaries, vasculitis affecting small vessels, vasospasm of tiny vessels, etc.

32
Q

Hour 1.5 to 4 of ischemia in the heart will show what gross findings? histopathology? Clinical correlations?

A
33
Q

4-12 hours of myocardial ischemia will show what gross findings? Histopathology? Clinial findings?

A
34
Q

What are contraction bands?

A

Contraction bands (AKA: contraction band necrosis) can occur in reperfusion injury, such as when therapeutic salvaging of myocardium is attempted. They represent hyper-contraction of injured myocytes, often on the periphery of the infarct, as calcium rushes into the cell. These myocytes may have lived, but in reperfusion, the biochemical changes that occur (like massive calcium influx) further injures marginally viable cells, pushing them into irreversible injury.

35
Q

12- 24 hours after myocardial ischemia what are the gross, histopathological, and clinical correlations?

A
36
Q

1-3 days after myocardial infarction shows what histopathological findings and clinical correlates?

A
37
Q

what does this image show?

A

This micro image is an infarct at 48 hours duration, and at this point, the predominant findings are coagulative necrosis (notice there are no myocyte nuclei visible, just myocyte ghost cells) and a neutrophilic infiltrate.

38
Q

At 3-7 days what are the gross, histopathological, and clinical features of myocardial ischemia?

A
39
Q

what are the histopathological findings seen at 7-10 days post myocardial ischemia?

A
40
Q

10-14 days post myocardial ischemia we see what histopathological and clinical correlates?

A

At about 10 days (although beginning much earlier), well-developed granulation tissue and angiogenesis can be seen. Marginal myocytes that were destined to live now are appearing more normal, and can be seen at the edge of the irreversibly injured myocytes

41
Q

2-8 weeks after myocardial ischemia what is gross, histopathologic, and clinical correlates we see?

A

After a few to several weeks, the infarcted region becomes collagenized during the wound healing process of scar. In the micro image stained with trichrome, new but incomplete collagen is being laid down and will fill in the space left by the intensive macrophage phagocytosis. Eventually the collagen will mature, contract, and fill in the space completely. It will also interdigitate at its edges with viable myocytes. After several weeks (such as gross image above), the lesion takes on the appearance of what is called a ‘remote’ infarct – cell death that happened in the past, and the further in the past it becomes, the less one can tell when it originally occurred.

42
Q

What are all the possible consequences of an MI?

A

Consequences of an infarct are well-establish and can be catastrophic. The location and size of the initial infarct determines to some degree the likelihood of the complications (arrhythmias more likely with septal infarcts; cardiogenic shock developing with large infarct areas, etc.)

  • cardiogenic shock – remaining myocytes cannot meet systemic demand; superimposed on other cardiac, pulmonary, renal, etc. issues, and mortality becomes significant.
  • mural thrombus – wall damage causing eddying or vascular stasis, combined with endothelial dysfunction, can lead to thrombosis (arrow, right image, mural thrombus on posterior wall)
  • pericarditis – see other Pericardium lecture
  • evolution towards chronic IHD – see below section
  • aneurysm formation (bottom right image) – a collagenized wall is much less strong than a muscular wall, and can undergo aneurysmal dilation
  • myocardial rupture (middle image above) – a rupture tract involving the posterior wall can be seen. Ruptures are most common when coagulative necrosis and neutrophils have effectively softened the wall, priming it to break open, during about the 2-5 day period. Note in this image, a posterior wall remote infarct is also present, and likely occurred before the current episode of myocardial injury.
  • papillary muscle dysfunction/rupture (left image above) – these changes can occur at any point, such as early rupture when coagulative necrosis is present, or much later, such as when wound healing/contraction can tether or pull on a papillary muscle. In the image, the papillary muscle has completely detached, because either it or the underlying myocardium has undergone likely necrosis.
  • arrhythmia – fatal or non-fatal conduction abnormalities of all types are possible. In addition, sudden cardiac death may be a consequence of an MI…
43
Q

Explain sudden cardiac death and the common patient presentation?

A

A lethal arrhythmia (asystole or ventricular fibrillation) is the most likely etiology of SCD, and usually patients have atherosclerotic CAD.

Consider the following scenario: An older patient (+/- known history of CAD, +/- other conditions, such as diabetes, HTN, etc.) dies suddenly and without any observer to the death. When that patient is evaluated/autopsied, there is no evidence of any catastrophic disease – no pulmonary embolism, no intracranial hemorrhage, no cerebral herniation, etc. Examination of the coronary arteries will often reveal moderate-severe atherosclerosis, but no evidence of plaque rupture, thrombosis, coronary artery embolus, etc. No significant (or only very minimal) gross or microscopic changes are observed.

This kind of patient has had most causes of sudden death ruled out, so the only remaining plausible diagnosis is SCD; in many cases, SCD effectively becomes a diagnosis of exclusion. It’s variably defined, but SDC represents 1) deaths that are unexpected and asymptomatic or 2) deaths that occur without warning within the first 24 hours of symptoms. The presumption is that the/a disease process has affected the conduction system, and there are almost no cues or clues to definitively prove this.

44
Q

Explain Chronic Ischemic heart disease?

A

Chronic IHD represents the variable spectrum of reduced cardiac function that can be seen in chronic ischemia. Patients may or may not have a history of previous MI.

  • chronic IHD as a consequence of MI: the heart is usually enlarged because myocytes have underwent compensatory hypertrophy. This hypertrophy is necessary, but may ultimately be insufficient, and a functional decompensation occurs (and can be called chronic IHD). In the image to the right, a remote infarct is seen in typical right coronary artery circulation. When considering the extent of the fibrosis and hypertrophy present, one may postulate that chronic IHD could be seen clinically, and that papillary muscle dysfunction/valvular abnormalities (note the papillary muscle fibrosis, arrow) may be present or contributing to the chronic IHD. The posterior wall is also fairly thin, and could be at risk for aneurysm at some point.
  • chronic IHD occurring without MI: progressive ischemic injury can lead to microscopic foci of fibrosis, representing small clusters of dead myocytes replaced by fibrosis. These won’t be visible grossly (i.e., no remote infarcts seen), but these foci can be scattered throughout the myocardium. As enough of these foci accumulate, cardiac function can be progressively affected.
45
Q

What are the determinants of oxygen supply and demand in the heart?

A

A. Oxygen supply. 1. Coronary blood flow. 2. Oxygen delivery. a. Hematocrit. b. Oxygen saturation.

B. Oxygen demand. 1. Blood pressure (afterload). 2. Ventricular volume (preload). 3. Heart rate. 4. Contractility

46
Q

What are some etiologies of ischemic heart disease?

A

A. Atherosclerotic heart disease (Most common).

B. Left ventricular outflow obstruction. 1. Aortic stenosis. 2. Hypertrophic cardiomyopathy. 3. Hypertension.

C. Miscellaneous causes. 1. “Pure” coronary artery spasm. 2. Arterial thrombi. 3. Coronary emboli (rare). 4. Arteritis (rare). 5. Luetic aortitis (rare). 6. Congenital abnormalities, e.g. anomalous origin of coronaries (rare). 7. Severe anemia. 8. Carboxyhemoglobinemia.

47
Q

What are the major causes of CAD? Explain atherosclerosis risk factors?

A

A. Atherosclerosis (risk factors). 1. Nonmodifiable. a. Age. b. Sex. c. Family history. 2. Modifiable. a. Hypertension (both systolic and diastolic). b. Hyperlipedemia (a 1% decrease in serum cholesterol is equivalent to a 2% reduction in cardiovascular risk). c. Cigarette smoking. d. Hyperglycemia (glucose intolerance). e. Obesity. f. Sedentary life-style. g. Psychological stress (type “A” behavior/ “hostility” complex). B. Coronary artery vasoconstriction. C. Platelet aggregation/thrombus formation. D. Combination of above responsible for majority of coronary artery disease.

48
Q

What are the effects of transient myocardial ischemia?

A

A. Metabolic—anaerobic metabolism resulting in lactic acid buildup with reduction in both the intracellular pH as well as myocardial stores of high energy phosphates.

B. Electrical disturbances. 1. Repolarization abnormalities of ischemia (ST-T wave changes). 2. Ventricular irritability (PVCs, V-tach, V-fib).

C. Mechanical effects of ischemia. 1. Dyskinesia of ischemic ventricular wall. 2. Wall motion abnormalities as detected by echocardiography, etc. 3. Myocardial stunning—prolonged post ischemic ventricular dysfunction without myocardial necrosis which may persist for minutes, hours, or even days after blood flow has been restored.

D. Angina pectoris = painful myocardial ischemia.

49
Q

Clinical Manifestations of ischemic heart disease?

A

A. Left heart failure.

B. Myocardial infarction.

C. Sudden cardiac death. 1. Definition: Within 24 hours. (More appropriately, within one hour). 2. Mechanism—ventricular fibrillation. 3. Brain damage begins within four minutes of cardiac arrest (without effective CPR); brain death certain in 10 minutes. 4. Diffuse coronary disease, and/or abnormal ventricular function are commonly noted. 5. Other cardiovascular etiologies: mitral valve prolapse, hypertrophic cardiomyopathy, aortic aneurysm, pulmonary thromboembolism. 6. Incidence: 640,000 deaths per year from coronary heart disease; approximately 60% occur within first symptom hour; approximately 350,000 deaths occur out of hospital. 7. Prodromal symptoms: sudden death may be first manifestation of coronary disease (25%); prodromal symptoms (17-79%). 8. Major risk factors for sudden death are similar to those of coronary heart disease.

D. Angina pectoris = painful myocardial ischemia. (Abnormal demand; inadequate supply).

50
Q

Typical characteristics of angina pectoris?

A
  1. Sensation of pain, pressure, burning, tightness.
  2. Located substernally with radiation to left or right shoulder or arm, jaw, teeth.
  3. May occur with dyspnea, and/or feelings of anxiety or dread.
  4. Related to exercise, cold, meals, motion or intercourse.
  5. Duration is 30 seconds to 20-30 minutes; relieved by rest and/or sublingual Nitroglycerin in 1-5 minutes.
51
Q

Differential diagnosis of chest pain?

A
  1. Cardiovascular (mitral valve prolapse, aortic stenosis, hypertrophic cardiomyopathy, dissecting aneurysm).
  2. Pulmonary (pulmonary embolism, pleurodynia, pleuritis, pneumonia).
  3. Neuromuscular (costochondritis, osteopathic rib lesions, etc.).
  4. Gastrointestinal (reflux esophagitis, hiatal hernia, peptic ulcer disease, gallbladder disease).
  5. Psychological (“soldier’s heart”, etc.).
  6. Disorders of unknown origin.
52
Q

Effort induced angina?

A

Effort induced angina: history of angina induced by exercise, relieved by rest and/or Nitroglycerin; lasting no longer than 15 minutes; 1 mm. or greater ST segment deviation on stress testing.

53
Q

Variant angina?

A

a. Prinzmetal’s angina. i. Frequent episodes of angina at rest (predominantly between midnight and 8:00 AM). ii. Transient ST segment elevation during angina which resolves during asymptomatic periods.
b. Coronary vasoconstriction. (Note: Prinzmetal’s angina is just a specific description of this phenomenon).

54
Q

What is mixed angina?

A

a. Definition: A form of angina caused by an atherosclerotic lesion coexisting with vasoconstriction.
b. Probably accounts for majority of anginal symptoms.

55
Q

What is unstable angina?

A

a. Anginal pain of increased frequency, increase intensity, increased duration, and decreased response to nitrates.
b. May also be considered “pre-infarction” angina.

56
Q

Evaluation of Coronary heart disease?

A

A. Initial evaluation. 1. History (most important). 2. Physical exam (not that helpful; observe for atrial gallop, etc.). 3. Resting EKG (can be normal despite the presence of ischemic heart disease). 4. Chest x-ray/fluoroscopy (not that helpful; observe for coronary calcifications). 5. Laboratory studies (serum cholesterol, etc.)

B. Additional testing. 1. Exercise stress testing. 2. Radionuclide studies. 3. Echocardiography (including stress echocardiography). 4. Coronary arteriography. 5. Left ventricular angiography.

57
Q

Indications for cardiac cath in symptomatic and non-symptomatic patients?

A
  1. Symptomatic patients. a. Noninvasive test results inconclusive. b. Evaluations/reassurance and unexplained chest pain. c. Document coronary artery spasm. d. Evaluation of indication for a bypass surgery.
  2. Asymptomatic patients. a. Abnormal resting EKG and those responsible for safety of others. b. Exercise EKG consistent with myocardial ischemia plus one or more major risk factors. c. M.I. in relatively young patient. d. Post cardiac resuscitation.
58
Q

Value of cardiac cath?

A

Value of cardiac catheterization. 1. Define coronary anatomy. 2. Evaluate left ventricular function. 3. Assessment of valvular heart disease, e.g. aortic valve gradient, etc.

59
Q

How do we manage a patient with angina pectoris?

A

A. General Goals. 1. Prolonged life. 2. Enhance quality of life.

B. Specific goals. 1. Slow/arrest/reverse(?) atherosclerotic process. 2. Control ischemic manifestations.

C. Therapeutic armamentarium for angina pectoris.

  1. Supportive therapies. a. Risk factor reduction. b. Control of aggravating conduction. c. Stress modification. d. Supervised exercise.
  2. Specific pharmacotherapy. a. Nitrates. b. Beta blockers. c. Calcium antagonists. d. Combination therapy. 3. Revascularization. a. Bypass surgery. b. Angioplasty.
60
Q

What are the therapeutic actions of Nitrates?

A
  1. Decrease myocardial oxygen demand. a. Reduce preload. b. Reduce afterload.
  2. Increase myocardial oxygen supply. a. Dilation of epicardial stenosis. b. Spasm block. c. Increased collateral flow.
61
Q

What are the available formulations of Nitrates?

A
  1. Sublingual. 2. Ointment. 3. Transdermal. 4. Oral. 5. Sustained action. 6. Buccal.
62
Q

Therapeutic actions of beta blockers?

A
  1. Decrease myocardial oxygen demand. a. Reduced heart rate. b. Reduced contractility. c. Reduced systolic blood pressure during exercise.
  2. Myocardial oxygen supply—no effect.
63
Q

Which beta blockers are vasoconstrictive/vasodilating? Other features of beta blockers?

A
  1. Vasoconstrictive (atenolol, metoprolol) v. vasodilating (carvedilol, nebivolol)
  2. Cardioselectivity.
  3. Intrinsic sympathomimetic activity.
  4. Hydrophilicity.
  5. Elimination half life.
64
Q

Therapeutic actions for Calcium channel blockers?

A
  1. Reduced myocardial oxygen demand. a. Reduced afterload. b. Slightly reduced preload. c. Slightly reduced contractility.
  2. Increased myocardial oxygen supply. a. Spasm prevented. b. Decreased coronary vascular resistance.
65
Q

Explain the features of Verapamil, Diltiazem, Nifedipine, and amlodipine?

A
  1. Verapamil (Isoptin, Calan)—most significant effect on cardiac conduction (especially AV node) of the three agents.
  2. Diltiazem (Cardizem) – also affects cardiac conduction
  3. Nifedipine (Procardia, Adalat), amlodipine (Norvasc) — most significant “unloading” effect of the three agents; no effect on cardiac conduction
66
Q

Explain Ranolazine?

A
  1. Prevents Na+ - induced Ca++ overload in ischemia and heart failure
    a. Increases myocardial oxygen supply i. Decreases diastolic wall tension (stiffness) (i) Decreases extravascualar compression thus increasing blood flow to microcirculation
    b. Decreases myocardial oxygen supply i. Decreases diastolic wall tension (stiffness) (i) Reduces tonic contractions
    c. No significant effect on heart rate and blood pressure
    d. Dose related prolongation of QT interval of questionable significance i. No evidence of torsade de pointes ii. May even have a primary anti-arrhythmic effect
67
Q

What are the indications and contraindications for Ranolazine?

A

B. Indications 1. Treatment of chronic angina 2. Should be used in combination with amlodipine and/or beta-blockers and/or nitrates

C. Contraindications / warnings 1. Avoid with preexisting QT prolongation or those on QT prolonging drugs 2. Avoid use in combination with potent and moderately potent CYP3A inhibitors a. Diltiazem b. Verapamil c. Macrolide antibiotics d. Azole antifungals e. Grapefruit juice

68
Q

Ranolazine dosing?

A

a. Initial dose 500 mg BID
b. May titrate up to 1000 mg BID
c. Baseline and follow-up ECG’s should be obtained

69
Q

Therapeutic actions of anti-platlet agents?

A
  1. Reduced platelets role in the development of an atherosclerotic lesion.
  2. Reduce thrombus formation.
  3. Will prevent thromboxane A release (promotes vasoconstriction from organized thrombus).